Gynaecological health care utilization and use of sex hormones - The study of Health in Pomerania

Human Reproduction

Volumn 20, Issue 10, 2005, Pages 2916-2922

  Schwarz, S ^a   Volzke H ^b   Alte, D ^b   Hoffmann, W ^b   John, U ^b   Dören, Martina ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Cervical cancer screening; Gynaecological surgery; HRT; Menopausal hormone therapy; Oral contraception

Indexed keywords

ORAL CONTRACEPTIVE AGENT; SEX HORMONE;

ADULT; AGED; ANAMNESIS; ARTICLE; CANCER SCREENING; COMPUTER AIDED DESIGN; FEMALE; GERMANY; GYNECOLOGIC SURGERY; GYNECOLOGY; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HEALTH EDUCATION; HEALTH SERVICE; HEALTH SURVEY; HIGH RISK POPULATION; HORMONE SUBSTITUTION; HUMAN; INTERVIEW; MENOPAUSE; ORAL CONTRACEPTION; OUTPATIENT DEPARTMENT; POPULATION RESEARCH; PREVALENCE; REPRODUCTIVE HEALTH; RISK ASSESSMENT; UTERINE CERVIX CANCER;

EID: 27144449911     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dei161     Document Type: Article

References (26)

1. Agency for Healthcare Research and Quality (2005) Management of menopause-related symptoms. AHRQ Publication No. 05-E016-2, pp 89-90 [accessible at: http://www.ahrq.gov/downloads/pub/evidence/pdf/menopause/ menopaus.pdf].
2. Anatomical Therapeutic Chemical (ATC) classification index with defined daily dose (DDD) (2000) Oslo WHO collaboration centre for drug statistics methodology [accessible at: http://www.whocc.no/atcddd/].
3. Bakken K Eggen AE and Lund E (2004) Side-effects of hormone replacement and influence on pattern of use among women aged 45-64 years. The Norwegian Women and Cancer (NOWAC) study 1997. Acta Obstet Gynecol Scand, 83,850-856.
4. Banks, E, Barnes, I, Baker, K and Key, T; EPIC Working Group on Reproductive and Hormonal Factors (2002) Use of hormonal therapy for menopause on nine European countries. IARC Sci Publ, 156, 301-303.
5. Bromley SE de Vries CS and Farmer RDT (2004) Utilisation of hormone replacement therapy in the United Kingdom. A descriptive study using the general practice research database. Br J Obstet Gynaecol, 111, 369-376.
6. BMFSFJ, (Bundesministerium für Familie, Senioren, Frauen und Jugend) (2001) Bericht zur gesundheitlichen Situation von Frauen in Deutschland [Federal Ministry of Family, Senior Citizens, Women and Youth. Report on the health-related situation of women in Germany]. W.Kohlhammer, Stuttgart, Germany.
7. Greiser E, Steding C and Janhsen K (2002) Hormone replacement therapy. Public health concern is serious. Br Med J 325,1243 [letter].
8. Hach I, Rentsch A, Ruhl UE, Becker ES, Türke V, Margraf J and Kirch W (2004) Drug use pattern in young German women and association with mental disorders. Ann Pharmacother, 38, 1529-1534.
9. Heitmann C, Greiser E and Dören M (2005) The impact of the Women's Health Initiative randomized controlled trial 2002 on perceived risk communication and use of postmenopausal hormone therapy in Germany. Menopause, in press.
10. Hemminki E and Blondel B; Study Group on Barriers and Incentives to Prenatal Care in Europe (2001) Antenatal care in Europe: Varying ways of providing high-coverage services. Eur J Obstet Gynecol, 94, 145-148.
11. Hersh AL, Stefanick ML and Stafford RS (2004) National use of postmenopausal hormone therapy. J Am Med Assoc, 291, 47-53.
12. Jantke A, Bühling KJ, Sehouli J, Pfüller B, Hindenburg H-J and Lichtenegger, W (2003) Zum Einfluss der WHI-Studie auf die Hormonsubstitution on der Praxis - Ergebnisse einer Umfrage unter Frauenärzten/innen in Berlin. Geburtsh Frauenheilk, 63, 560-565. [The impact of the WHI study - results of a survey among gynecologists in Berlin.]
13. John U, Greiner B, Hensel E, Lüdemann J, Piek M, Sauer S, Adam C, Born G, Alte D, Greiser E et al (2001) Study of Health in Pomerania (SHIP): A health examination survey in an east GOrman region: objectives and design. Soz Praventivmed, 46, 186-194.
14. Knopf H and Melchert H-U (1999) Subjektive Angaben zur täglichen Anwendung ausgewählte Arzneimittelgruppen - Erste Ergebnisse des Bundesgesundheits-surveys 1998 [Subjective statements regarding use of selected drug groups-initial results of the 1998 Federal Health Survey]. Gesundheitswesen, 61, S151-S157.
15. Li C, Samsioe G, Lidfeldt J, Nerbrand C and Agardh CD (2000) Important factors for use of hormone replacement therapy: A population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study. Menopause, 7, 273-281.
16. Löwel, H, Heier, M, Schneider, A, Gösele, U and Meisinger, C (2003) Hormontherapie. Vergleiche sind zulässig [Hormone therapy - comparisons are justified]. Deutsches Ärzteblatt, 40, 2008-2009.
17. Lundberg V, Tolonen H, Stegmayr B, Kuulasmaa K and Asplund K; WHO MONICA Project (2004) Use of oral contraceptives and hormone replacement therapy in the WHO MONICA project. Maturitas, 48, 39-49.
18. Million Women Study Collaborators (2002) Patterns of use of hormone replacement therapy in one million women in Britain, 1996-2000. Br J Obstet Gynaecol, 109, 1319-1330.
19. Müller JE, Döring A, Heier M and Löwel H (2002) Prevalence and determinants of hormone replacement therapy in German women 1984-1995. Maturitas, 43, 95-104.
20. Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N, Wallace RB, Jackson RD, Pettinger MB and Ridker PM (2002) Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease. J Am Med Assoc, 288, 980-987.
21. Schaffer JI and Word A (2002) Hysterectomy - still a useful operation. New Engl J Med, 347, 1360-1362.
22. Schenk U and von Karsa L (2000) Cervical cancer screening in Germany. Eur J Cancer, 36, 2221-2226.
23. Schwabe U and Rabe T (2004) Sexualhormone. In Schwabe U and Paffrath D (eds) Arzneiverordnungsreport 2004 [Report upon pharmacotherapy prescriptions year 2004]. Springer, Berlin, Germany, pp 835-856.
24. Settnes A, Lange AP and Jorgensen T (1997) Gynaecological correlates of hysterectomy in Danish women. Int J Epidemiol, 26, 364-370.
25. Statistisches Landesamt Mecklenburg-Vorpommern (1999) [Statistical bureau of the state of Mecklenburg-Vorpommern].
26. World Health Organization Scientific Group on Research on the Menopause in the 1990s (1996) Research on the menopause. Report of a WHO scientific group, Geneva, Switzerland. WHO Technical Report Series 866.